Sedative and Immunosuppressive Effects of Dexmedetomidine in Transplantation
Dexmedetomidine, an α2-adrenergic receptor agonist, is used as an anti-anxiety medication. It exerts a cholinergic effect, thereby reducing the release of tumor necrosis factor alpha (TNF-α). We hypothesized that the use of dexmedetomidine as a sedative agent in transplantation would also protect al...
Main Authors: | Chen-Fang Lee, Chih-Hsien Cheng, Hao-Chien Hung, Jin-Chiao Lee, Yu-Chiao Wang, Tsung-Han Wu, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan, Wei-Chen Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/8/825 |
Similar Items
-
Dexmedetomidine sedation in ICU
by: Soo-Bong Yu
Published: (2012-05-01) -
Dexmedetomidine versus Propofol Sedation for Prevention of Postoperative Delirium: Clarifications Required [Letter]
by: Deng J, et al.
Published: (2021-07-01) -
Dexmedetomidine Based Sedation for Post-surgery Critically Ill Adults: A Meta-analysis of Randomized Controlled Trials
by: Heng FAN, et al.
Published: (2017-11-01) -
Sedation with dexmedetomidine reduces the duration of delirium treatment in sufferers with severe concomitant trauma
by: F. F. Bershadskiy, et al.
Published: (2018-01-01) -
Dexmedetomidine for sedation in intensive care. Literature review and clinical experience
by: Dmytro Dmytriiev, et al.
Published: (2020-06-01)